These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37938506)

  • 41. Eligibility of patients with temporary paced rhythm for a subcutaneous implantable cardioverter-defibrillator.
    Opielowska-Nowak B; Kempa M; Budrejko S; Sławiński G; Raczak G
    Kardiol Pol; 2022; 80(12):1231-1237. PubMed ID: 36052564
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Predictors for need of antibradycardia and antitachycardia pacing after ICD implantation : Implications for the subcutaneous ICD].
    Grett M; Christ M; Trappe HJ
    Herzschrittmacherther Elektrophysiol; 2016 Dec; 27(4):390-395. PubMed ID: 27738753
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of myopotential induction in subcutaneous implantable cardioverter-defibrillator patients: Is the oversensing issue really solved?
    van den Bruck JH; Sultan A; Plenge T; Seuthe K; Mödder T; Iliadis C; Stern D; Blankenheim T; Steven D; Lüker J
    Heart Rhythm; 2019 Oct; 16(10):1523-1530. PubMed ID: 31048064
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lead Abandonment and Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) Implantation in a Cohort of Patients With ICD Lead Malfunction.
    Russo V; Viani S; Migliore F; Nigro G; Biffi M; Tola G; Bisignani G; Dello Russo A; Sartori P; Rordorf R; Ottaviano L; Perego GB; Checchi L; Segreti L; Bertaglia E; Lovecchio M; Valsecchi S; Bongiorni MG
    Front Cardiovasc Med; 2021; 8():692943. PubMed ID: 34395560
    [No Abstract]   [Full Text] [Related]  

  • 45. Use of pulsed electron avalanche knife (PEAK) PlasmaBlade™ in patients undergoing implantation of subcutaneous implantable cardioverter-defibrillator.
    Kaya E; Siebermair J; Azizy O; Dobrev D; Rassaf T; Wakili R
    Int J Cardiol Heart Vasc; 2019 Sep; 24():100390. PubMed ID: 31334332
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance and outcome of the subcutaneous implantable cardioverter-defibrillator after transvenous lead extraction.
    Chung DU; Tauber J; Kaiser L; Schlichting A; Pecha S; Sinning C; Rexha E; Reichenspurner H; Willems S; Gosau N; Hakmi S
    Pacing Clin Electrophysiol; 2021 Feb; 44(2):247-257. PubMed ID: 33377195
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Eligibility of cardiac resynchronization therapy patients for subcutaneous implantable cardioverter defibrillators.
    Giammaria M; Lucciola MT; Amellone C; Orlando F; Mazzone G; Chiarenza S; Lovecchio M; Valsecchi S
    J Interv Card Electrophysiol; 2019 Jan; 54(1):49-54. PubMed ID: 30187250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eligibility for subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease.
    Zormpas C; Silber-Peest AS; Eiringhaus J; Hillmann HAK; Hohmann S; Müller-Leisse J; Westhoff-Bleck M; Veltmann C; Duncker D
    ESC Heart Fail; 2021 Apr; 8(2):1502-1508. PubMed ID: 33538124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies.
    Brouwer TF; Knops RE; Kutyifa V; Barr C; Mondésert B; Boersma LVA; Lambiase PD; Wold N; Jones PW; Healey JS
    Europace; 2018 Sep; 20(FI2):f240-f248. PubMed ID: 29771327
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 52. His bundle pacing for newly acquired pacing needs in patients implanted with a subcutaneous implantable cardioverter defibrillator: A feasibility study based on the automated screening score and clinical cases.
    Gauthey A; Calle S; Accinelli S; Depuydt P; Garnir Q; Scavée C; Marchandise S; Wauters A; Bordachar P; de Pooter J; le Polain de Waroux JB
    J Cardiovasc Electrophysiol; 2020 Jul; 31(7):1793-1800. PubMed ID: 32412155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New Innovative Pacemaker Devices - Leadless Pacemaker, Subcutaneous ICD].
    Napp A; Reith S
    Dtsch Med Wochenschr; 2018 Nov; 143(22):1617-1622. PubMed ID: 30376685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Security millimetre wave body scanner safe for patients with leadless pacemakers or subcutaneous implantable cardioverter-defibrillators.
    Blažek P; O'Connor MJ; Weigand S; Grebmer C; Reif S; Fichtner S; Friedrich L; Reents T; Kottmaier M; Semmler V; Bourier F; Schunkert H; Deisenhofer I; Kolb C; Lennerz C
    J Interv Card Electrophysiol; 2021 Sep; 61(3):603-607. PubMed ID: 32860605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
    Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
    Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SMART pass will prevent inappropriate operation of S-ICD.
    Tachibana M; Nishii N; Banba K; Fujita S; Ikeda E; Okawa K; Morita H; Ito H
    J Arrhythm; 2019 Feb; 35(1):86-91. PubMed ID: 30805048
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment Strategy for Fatal Arrhythmias in Ebstein's Anomaly Combined With Leadless Pacemaker and S-ICD Implantations.
    Takami M; Fukuzawa K; Kiuchi K; Matsumoto K; Izawa Y; Hirata KI
    JACC Case Rep; 2022 Dec; 4(23):101464. PubMed ID: 36507289
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined therapy with subcutaneous implantable cardiac defibrillator and leadless pacemaker in a patient with persistent left superior vena cava and mega coronary sinus: A challenging case for the best treatment.
    Gatto MC; De Sanctis V; Percoco F; Persi A; Dominici T; Moretti A; Evangelista F; Mantica M; Kol A
    J Arrhythm; 2021 Oct; 37(5):1364-1367. PubMed ID: 34621440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.